LeReve Regenerative Wellness
- PRP Therapy
- IV Therapy
- Acne Treatment
- Arthritis Treatment
- Peptide Therapy
San Jose, CA
Peptide Therapy clinics in San Jose
San Jose has Silicon Valley longevity demand filtered through California's stricter pharmacy oversight, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across Willow Glen, Los Gatos, Saratoga, and Cupertino range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the Stanford Health Care and Kaiser Santa Clara network. The scene here skews toward clinics serving a tech-executive patient base focused on long-term optimization. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable San Jose clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.
MD on staff
NexGen Health
- NAD IV Therapy
- Vitamin IV Therapy
- Ozone Therapy
- IV Therapy
- Laser Therapy (LLLT)
Gameday Men's Health South
- PRP Therapy
- Shockwave Therapy
- IV Therapy
- Arthritis Treatment
- Peptide Therapy
MD on staff
LUMINANCE REGENERATIVE BEAUTY & WELLNESS
- Stem Cell Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- PRP Therapy
- IV Therapy
Shasa Medical Group
- Acne Treatment
- Peptide Therapy
- Red Light Therapy
- Hormone Replacement Therapy (HRT)
Excel Medicine
- PRP Therapy
- IV Therapy
- Hyperbaric Oxygen Therapy (HBOT)
- Oxygen Therapy
- Acne Treatment
Revive Body MD
- Vitamin IV Therapy
- Peptide Therapy
- Red Light Therapy
- Hormone Replacement Therapy (HRT)
The Hydration Room
- Stem Cell Therapy
- NAD IV Therapy
- Vitamin IV Therapy
- IV Therapy
- IV Hydration
Stemaid Institute
- Ozone Therapy
- Multiple Sclerosis (MS) Treatment
- Arthritis Treatment
- Chelation Therapy
- Lyme Disease Treatment
Peptide, TRT and Menopause Therapy Speicalist
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Testosterone Replacement Therapy (TRT)
- Hormone Replacement Therapy (HRT)
AgeDefy Hormone Replacement Therapy Studio
- Arthritis Treatment
- Peptide Therapy
- Erectile Dysfunction (ED) Treatment
- Hormone Replacement Therapy (HRT)
- Testosterone Replacement Therapy (TRT)
Regulatory context
A note on California's peptide therapy rules.
Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. In 2023 and 2024 the FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list, which restricts 503A compounding pharmacies from sourcing those ingredients for patient-specific prescriptions. Section 503A covers traditional pharmacies; Section 503B covers FDA-registered outsourcing facilities operating under cGMP.
-
California Business and Professions Code Division 2 Chapter 9 (Pharmacy Law)
Governs compounding, licensure, and sourcing under the California State Board of Pharmacy. -
California Code of Regulations Title 16 Section 1735 et seq.
Sets compounding standards for sterile and non-sterile preparations. -
California Business and Professions Code Section 2052
Defines practice of medicine and limits who may prescribe or administer drugs. -
California Naturopathic Doctors Act
Grants licensed NDs limited prescriptive authority under formulary advisory committee rules.
The California State Board of Pharmacy inspects sterile compounding facilities under stringent state rules that often exceed USP 797. The Board has issued citations for sourcing non-compliant bulk ingredients and for office-use stocking that should have flowed through a 503B. Non-resident pharmacies shipping into California must hold a current non-resident permit; the Board publishes disciplinary actions and annual inspection findings. Clinics dispensing from in-office stock of compounded peptides are examined closely.